(QUI) and to value the medical intervention after the determination of the bone mineral density (BMD). Methods: Cross-sectional descriptive study developed in a community pharmacy. During the month of June of 2005 the community pharmacy enrolled postmenopausal women into the study. Women in treatment with calcium, vitamin D, hormone replacement therapy, estrogen receptor modulators, calcitonin or biphosphonates were considered criteria for exclusion. To all the women that consent to participate, the pharmacist measured BMD with the device Sahara Hologic Ultrasound Bone Densitometer at right calcaneus. Following the World Health Organization, women were classified as osteoporotic if their T-Score was less than -2.5 and as osteopenic if their T-Score ranged between -2.5 and -1.0. Results: Of the 100 women screened, 11 (11%) presented risk of osteoporosis and 61 (61%) of osteopenia. The 18.5% postmenopausal women with body mass index lesser than 30 presented risk of osteoporosis and the 63.0% osteopenia. Conclusions: The QUI constitutes a useful tool in community pharmacy for the screening of osteoporosis and it supposes a greater integration of the community pharmacy within the health care. Keywords RESUMENObjetivos: Identificar mujeres posmenopáusicas con riesgo de osteoporosis mediante ultrasonografía ósea cuantitativa y valorar la intervención médica tras la determinación de la densidad mineral ósea. Métodos: Estudio descriptivo transversal desarrollado en una farmacia comunitaria mediante la selección de las mujeres posmenopáusicas que acudieron durante el mes de junio de 2005. Se consideró criterio de exclusión estar en tratamiento con calcio, vitamina D, terapia hormonal sustitutiva, raloxifeno, calcitonina o bifosfonatos. A todas las mujeres que acceden a participar se les realizó un ultrasonografía ósea en el calcáneo derecho con el dispositivo Sahara (Hologic). Se aplicaron los criterios de clasificación de la Organización Mundial de la Salud, que clasifican a los pacientes con una DMO de más de 2,5 desviación estándar inferior a la media de una adulto joven (T-Score < -2,5) como osteoporótico, y a los pacientes con T-Score entre -1 y -2,5 como osteopénicos. Resultados: De las 100 mujeres estudiadas, 11 (11%) presentaban riesgo de osteoporosis y 61 (61%) riesgo de osteopenia. El 18,5% de las mujeres con un índice de masa corporal < 30 presentaba riesgo de osteoporosis y el 63% osteopenia. Conclusiones: La ultrasonografía ósea cuantitativa constituye una herramienta útil en farmacia comunitaria para el cribado de osteoporosis y supone una nueva vía de integración en la atención sanitaria.Palabras clave: Osteoporosis. Osteopenia. Cribado. Ultrasonografía. España. (English) INTRODUCTIONOsteoporosis is a systemic disease of the skeleton, characterised by low bone mass and alterations in the micro-architecture of the bone tissue that lead to an increase in brittleness with the ensuing predisposition to bone fractures.1 In 1994 the World Health Organisation (WHO) established diagnostic criteria based on the ...
Se analizan algunos elementos que, a juicio del autor, inciden gravemente en la actual crisis del ejercicio de la Medicina. ¿Es la Medicina una ciencia, una técnica, un arte?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.